🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

11375+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 11375 recruiting trials

Phase 1RecruitingNCT06556394

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation

🏥 Ractigen Therapeutics.📍 3 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06987552

Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients

👨‍⚕️ Shih-Chieh Chueh, National Taiwan University Hospital📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06756308

A Study of Enasidenib in People With T-Cell Lymphoma

👨‍⚕️ Zachary Epstein-Peterson, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Dec 2024View details ↗
RecruitingNCT07454343

ECD-Score: a Study on Erdheim-Chester Disease

👨‍⚕️ Augusto Vaglio, Medical Doctor, Meyer Children's Hospital IRCCS📍 7 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06705387

Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE

🏥 University of Colorado, Denver📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06805695

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

👨‍⚕️ George Diaz, M.D., Ph.D, iECURE, Inc.📍 1 site📅 Started Dec 2024View details ↗
NAEnrolling by InvitationNCT06817902

TMS Pilot in Early AD II

👨‍⚕️ Bhavani Kashyap, MBBS, PhD, HealthPartners Institute📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06660355

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

👨‍⚕️ Farhad Khimani, MD, Moffitt Cancer Center📍 4 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06852638

CD70-targeted immunoPET Imaging of Malignant Cancers

👨‍⚕️ Jianjun Liu, Ph.D. & M.D., Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06830356

Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.

👨‍⚕️ Lorenzo Vinante, Centro di Riferimento Oncologico di Aviano (CRO)📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06742697

Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia

👨‍⚕️ Leonardo Boccuni, PhD, Scientific Institute, IRCCS E. Medea, Department of Conegliano, Treviso, Italy.📍 2 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06752668

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

🏥 Centessa Pharmaceuticals (UK) Limited📍 29 sites📅 Started Dec 2024View details ↗
RecruitingNCT06795152

Rare Glycogen Storage Diseases Natural History Study

👨‍⚕️ Priya Kishnani, M.D., Duke📍 1 site📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06635902

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

👨‍⚕️ Suvankar Majumdar, MD, Children's National Research Institute📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06657911

Size Up Bicuspid with the LIra MEthod: the SUBLIME Study

👨‍⚕️ Prof. Matteo Montorfano, MD, IRCCS San Raffaele Scientific Institute📍 5 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06561347

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

👨‍⚕️ Andrew Branagan, MD, PhD, Massachusetts General Hospital📍 5 sites📅 Started Dec 2024View details ↗
NARecruitingNCT06718907

Mitigating Response to Stressors in Pregnant Women

👨‍⚕️ Gesulla Cavanaugh, PhD, MPH, MS, Nova Southeastern University📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06819449

Rab 32 Gene Polymorphisms as a Prognostic Factor in Leprosy Patients

👨‍⚕️ Eisa Mohammed Hegazy, Assist. Prof, Dermatology, Venereology and Andrology. Faculty of Medicine,South Valley University📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT06786078

The Lily Device Trial

🏥 Luminate Medical, Inc.📍 5 sites📅 Started Dec 2024View details ↗
EARLY_Phase 1RecruitingNCT06424301

Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma

👨‍⚕️ Chen Zhao, MD, Fudan Eye & ENT Hospital📍 1 site📅 Started Dec 2024View details ↗
← PreviousPage 185 of 569Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →